News summary

[Leo Shares: Hope to increase investment in Suzhou Zhixin Haozheng is currently under negotiation] Securities Times e Company News, Leo Shares (002131) stated on the interactive platform that the company has participated in the investmentleagueoflegendsblockchainSuzhou Zhixin Haozheng Regenerative Medicine Technology Co., Ltd.(Suzhou Zhixin Haozheng Regenerative Medicine Technologyleagueoflegendsblockchain...

Newsletter text

[Leo shares: Hope to increase investment in Suzhou Zhixin Haozheng is currently under negotiation] Securities Times e Company News, Leo shares (002131) stated on the interactive platform that the company has invested in Suzhou Zhixin Haozheng Regenerative Medicine Technology Co., Ltd.(Suzhou Zhixin Haozheng Regenerative Medicine Technology Co., Ltd. holds 100% equity of Zhixin Haozheng (Shanghai) Life Sciences Co., Ltd.), with a small shareholding ratio. The company hopes to increase its investment in Suzhou Zhixin Haozheng, and is currently under negotiation and there is uncertainty. Suzhou Zhixin Haozheng Regenerative Medicine Technology Co., Ltd. is a medical technology company that uses stem cells to differentiate and regenerate islet tissue to treat diabetes as its research and development and industrialization direction.